# Eptifibatide

NDC: 67457-631
Generic name: eptifibatide
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20181213

FDA application: ANDA203258

## Active ingredients

- EPTIFIBATIDE: .75 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-631"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-631
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88a37f9c-496b-4a6b-9665-4550abba04f1